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REVIEW
ab T cell receptors as predictors of health and disease
Meriem Attaf1, Eric Huseby2 and Andrew K Sewell1
The diversity of antigen receptors and the specificity it underlies are the hallmarks of the cellular arm of the adaptive
immune system. T and B lymphocytes are indeed truly unique in their ability to generate receptors capable of recognizing
virtually any pathogen. It has been known for several decades that T lymphocytes recognize short peptides derived from
degraded proteins presented by major histocompatibility complex (MHC) molecules at the cell surface. Interaction
between peptide-MHC (pMHC) and the T cell receptor (TCR) is central to both thymic selection and peripheral antigen
recognition. It is widely assumed that TCR diversity is required, or at least highly desirable, to provide sufficient immune
coverage. However, a number of immune responses are associated with the selection of predictable, narrow, or skewed
repertoires and public TCR chains. Here, we summarize the current knowledge on the formation of the TCR repertoire and
its maintenance in health and disease. We also outline the variousmolecular mechanisms that govern the composition of
the pre-selection, naive and antigen-specific TCR repertoires. Finally, we suggest that with the development of
high-throughput sequencing, common TCR ‘signatures’ raised against specific antigens could provide important
diagnostic biomarkers and surrogate predictors of disease onset, progression and outcome.
Cellular & Molecular Immunology (2015) 12, 391–399; doi:10.1038/cmi.2014.134; published online 26 January 2015
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INTRODUCTION
T cells orchestrate immune responses by interrogating protein
expression via peptides cradled in major histocompatibility
complex (MHC)molecules at the cell surface. The T cell recep-
tor (TCR) is the fundamental unit underlying all peptide-MHC
(pMHC) recognition events. In the thymus, T cell signalling
induced by self-pMHC engagement contributes to the process
of selection at the double-positive stage, whereby only a frac-
tion of thymocytes bearing TCRs within a narrow affinity range
are permitted to differentiate intomature T cells.1 In secondary
lymphoid organs, ligation of the TCR to pMHC provides the
cell with the earliest signals required for the execution of a
complex differentiation programme associated with effector
function. In the steady state, homeostasis of T cell numbers is
also MHC-dependent.2
The TCR is a heterodimer of one a and one b chain, or one c
and one d chain, which are disulphide-linked.3,4 Each TCR
chain is composed of a constant and a variable domain, fol-
lowed by a membrane-spanning region and a short cytosolic
tail. Diversity in the TCR is predominantly confined to six
hypervariable hairpin loops in the variable domains, called
complementarity-determining regions5 (CDR) (Figure 1a).
TCR chains are assembled somatically during T cell develop-
ment by the joining of discrete V, (D) and J gene segments by
recombination activating gene (RAG)1 and RAG2 (Figures 1b
and 2). The process of V (D) J recombination is such that
CDR1a, CDR1b, CDR2a and CDR2b are entirely encoded in
germline DNA segments. In contrast, the CDR3 loops are the
product of junctional diversity and are consequently hypervari-
able (Figure 1b).
Gene rearrangement is an essential event in the life of a T cell.
Expression of RAG1 and RAG2 is lymphoid-specific and dic-
tates irreversible T cell lineage commitment in developing thy-
mocytes.6 Moreover, gene rearrangement provides the T cell
compartment with sufficient diversity to sustain protective
immunity. Indeed, the importance of receptor diversification
is apparent in murine models and in a number of primary
immunodeficiencies in humans. For instance, rag-deficient
mice are devoid of T and B lymphocytes.7 In humans, rag
deficiency is linked to severe combined immunodeficiency,
and other rag mutations can lead to immunodeficiency with
expansion of cd T cells or with idiopathic CD41 T cell lympho-
paenia. Mis-sense mutations in rag1 and rag2 are the cause of
Omenn syndrome, a disease with graft-versus-host disease-like
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clinical presentation.8,9 Omenn syndrome is characterized by
expansion of autoreactive CD41 T cells with an oligoclonal
repertoire and is fatal to infants between 2 and 6 months of
age as a result of recurrent infections.10
The theoretical diversity in the TCR-ab repertoire is esti-
mated at 1015 clones in mice11 and 1018 in humans.12 Most of
these specificities will never be used during an individual’s
lifetime, as the murine and human peripheral repertoires are
composed of 2 million13 and 25 million14 clonotypes, respec-
tively. Out of 25 million human TCRs, some clonotypes
referred to as ‘public’ TCRs can be found in different indivi-
duals, while others are largely unique to an individual and are
said to be ‘private’.
The molecular principles that dictate which TCRs are
assembled and selected to seed the peripheral pool, which are
shared between individuals and which are private are only
starting to emerge. Dissecting the distribution of TCR clono-
types within an individual, and across individuals, in health
and disease is critical to our understanding of protective T
cell-mediated responses. In this review, we discuss the various
factors working to shape the pre-selection, naive and antigen-
specific TCR repertoires. We bring particular attention to
recent studies which suggest that TCR ‘signatures’ shared
across genetically disparate individuals may become important
diagnostic tools and predictors of immune protection or
disease.
TCR DIVERSITY IN THE PRE-SELECTION REPERTOIRE
Gene rearrangement is typically thought of as an inherently
random process. Intuitively, stochastic diversification of the
repertoire would seem advantageous, maximizing potential
immune coverage without prior bias towards certain specifici-
ties. However, numerous studies have demonstrated that the
complexity of the repertoire is not achieved at random. Rather,
generation of diversity in ab T cells is tightly regulated and the
composition of the repertoire, even prior to thymic selection is
highly structured.
Both genetic and epigenetic factors influence the composi-
tion of the pre-selection repertoire. The ‘accessibility hypo-
thesis’15 posits that in order for recombination to take place,
gene segments must first be made accessible to the recombina-
tion machinery. This in turn depends on subnuclear relocation
of the rearranging TCR loci (tr), DNA methylation status,
recruitment of chromatin remodelling enzymes, histone modi-
fication and germline transcription. The mechanisms involved
in spatial and temporal control of V (D) J recombination have
been reviewed elsewhere.16
Activation of the 39 proximal region of antigen receptor loci
is well characterized and known to be dependent on activation
of a local enhancer. However, the factors that govern the acces-
sibility and activation of the 59 V region are less clear.17,18 In
particular, whether differential accessibility and activation sta-
tus of V genes can affect the composition of the resulting
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Figure 1 TCR protein and gene structure. (a) Structure of the AS01 TCR.39 The TCR-a and TCR-b CDR loops are short hairpin turns
linking adjacent b-strands. (b) CDR1 and CDR2 are entirely encoded in the germline V genes, whereas CDR3 lies at the junction between
the rearranged V and J segments (TCR-a) and V, D and J segments (TCR-b). The CDR3 junctional sites are assembled by random addition
and deletion of template and non-template nucleotides (blue for TCR-a and orange for TCR-b). CDR, complementarity-determining region; TCR, T
cell receptor.
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repertoire is largely unknown. In the immunoglobulin heavy
chain (Igh) locus, distal V genes have been shown to have
higher levels of active histone markers compared to proximal
segments, which suggests that different V elements recombine
at different frequencies despite being equally accessible to the
recombinationmachinery.19Whether this is also true for tr loci
has yet to be determined.
Recently, a comprehensive analysis of the mouse TCR-a
repertoire revealed that the frequency of out-of-frame
sequences was dependent on V and J segment usage, suggesting
that the production of out-of-frame, non-functional TCR-a
chains is genetically determined.20 Moreover, syngeneic mice
have been shown to display at least 15% overlap in the TCR-b
chain repertoire. Most of this overlap is attributed to recombi-
natorial bias, as the vast majority of shared sequences are
observed even in the pre-selection repertoire.21 An earlier study
looking into the TCR-b chain repertoire of TCR-a2/2 mice
had already suggested recombinatorial bias in the pre-selection
repertoire. In TCR-a2/2 mice, the TCR-ab receptor is not
expressed, providing insight into the composition of the rear-
ranged TCR-b pool in the absence of thymic selection. In this
setting, 11% of all analysed sequences were repeats.22
Altogether, these studies, and others, suggest bias in the
composition of the TCR repertoire prior to any contribution
from thymic selection. Notably, V (D) J recombination deter-
mines the extent of TCR sharing between different individuals,
irrespective of MHC haplotype.
TCR DIVERSITY IN THE NAIVE POOL
Successfully rearranged TCRs are expressed at the T cell surface
and audition for selection on thymic self-pMHC ligands. The
net result of thymic selection is that the post-selection re-
pertoire is largely purged of most clonotypes.23 Typically, only
one in a hundred thymocytes are thought to be granted access
to the periphery24 (Figure 3). Assessing the relative distribution
of TCR clonotypes has long been a challenge in the naive pool
because of low precursor frequency. Nevertheless, identifying
the factors that shape the composition of the naive repertoire is
critical to our understanding of protective T cell-mediated
immunity because naive lymphocytes represent the precursor
pool from which all immune responses arise.
The size and diversity of the post-selection thymocyte popu-
lation is regulated by the ligands made available in the thymus
by antigen processing and presentation.25,26 Polymorphism at
themhcwill affect an individual’s TCR repertoire by determin-
ing the collection of peptides that can be presented to T cells
during development.27–29 The role of theMHC-bound peptide
in positive selection was made clear from experiments with
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Figure 2 Gene rearrangement at the tr loci. (a) VJ recombination at the tra locus. The tra locus (in which the TCR-d, or trd locus is also embedded)
comprises a 59 V gene segment cluster (46 TRAV segments) followed by a central J cluster (51 TRAJ segments) and a single C gene segment
(TRAC). TCR-d D and J segments (TRDD and TRDJ, respectively) are also present in the locus. V to J recombination brings together one of many
TRAV segments to one of many TRAJ segments. The intervening sequences are spliced out, producing a TCR-a transcript in which V, J and C
segments are directly adjacent. (b) VDJ recombination at the trb locus. The trb locus is composed of a 59 V cluster (48 TRBV gene segments)
followed by two 39 TRBD–TRBJ–TRBC clusters. VDJ recombination is a two-step, ordered process. D to J recombination occurs first, juxtaposing
TRBD1 to one of the six TRBJ1 segments or TRBD2 to one the seven TRBJ2 segments. V to DJ recombination subsequently brings the rearranged
DJ join to one of many TRBV segments. The intervening sequences are then spliced out, generating a TCR-b transcript in which, V, D, J and C
segments are directly adjacent. TCR, T cell receptor.
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foetal thymic organ cultures in which themajor route for class I
MHC loading and surface expression was blocked by deficiency
in the transporter associated with antigen processing 1. In trans-
porter associated with antigen processing 1-deficient foetal thy-
mic organ cultures, the addition of exogenous peptide
enhanced class I expression and improved the selection of
mature CD81 T cells.30 Later experiments demonstrated that
larger peptide mixtures were better at positively selecting T cells
with a broad repertoire than single peptides,31 suggesting that
peptide diversity in the thymic stroma correlates with TCR
diversity.
At least one other component of the antigen processing
machinery, ER-associated aminopeptidase 1 (ERAP1) is also
highly polymorphic. Single nucleotide polymorphisms in
ERAP1 are inherited as haplotypes, some of which are linked
to autoimmune disease.32 ERAP1 trims peptides entering the
ER in order to increase the frequency of peptides of appropriate
length for binding to class I MHC molecules. Of note, ERAP1
activity can lead to peptide over-trimming and destruction.
Therefore, allelic variants of ERAP1, with distinct trimming
properties, will also influence the composition of the repertoire
by determining the identity and abundance of peptides pre-
sented to CD81 T cells.32
Nitta et al.33 have shown that mice deficient in the thymo-
proteasome subunit b5t select fewer CD81 T cells than b5t-
sufficient mice. In this setting, CD81 T cells display reduced
TCR diversity, which demonstrates that the peptides generated
by the unique catalytic activity of the thymoproteasome affect
the composition of the repertoire. Similarly, in knock-in mice
in which the immunoproteasome b5i subunit replaces b5t,
positive selection is compromised.34
In summary, TCRs auditioning for selection are picked in a
deterministic manner. The factors controlling selection
encompass some of the major components of the antigen pro-
cessing machinery, which determine the peptide universe ge-
nerated in the thymus.
TCR BIAS IN ANTIGEN-SPECIFIC RESPONSES
The thymus involutes with age and thymic output is reduced as
a consequence but the composition of the repertoire remains
remarkably constant throughout life, except in infancy and old
age.35 Homeostatic regulation ensures that most specificities
generated by the thymus are maintained during the lifetime of
the individual.36,37 However, the relative abundance of each
specificity is modulated by the individual’s history of antigen
exposure, as antigen-driven selection in the periphery leads to
differential expansion of specific TCR clonotypes. It follows
that TCR diversity is the highest in the naive compartment,
with the antigen-experienced repertoire being skewed towards
just some of these specificities36,38 (Figure 3).
In mice, the emergence of a diverse repertoire is a predictor
of good disease outcome. Messaoudi et al.29 showed that wild-
type C57BL/6 mice (H-2b) infected with herpes simplex virus-1
select for a significantly narrower repertoire, compared to a co-
isogenic strain (H-2bm8) which differed only by expression of a
H-2Kmolecule with four amino acidmutations in the peptide-
binding groove. Strikingly, H-2bm8 mice showed resistance to
infection and increased survival compared to their wild-type
counterpart, which led the authors to conclude that the expan-
sion of additional TCRs was necessary and sufficient to confer
protection against herpes simplex virus-1. Indeed, in this sys-
tem, herpes simplex virus-1 resistance was strictly conveyed by
Vb8-expressing T cells.
Some human infections paint a different picture. Infections
with common pathogens give rise to highly skewed and pre-
dictable repertoires with clonotypes reported to be shared
across HLA-matched individuals. Thus, the advantage of hav-
ing a diverse repertoire is not always apparent in human dis-
ease. The occurrence of shared TCRs is explained by
convergent recombination, whereby certain TCR sequences
are produced at high frequency (this is the case for near germ-
line sequences requiring few nucleotide additions), and by the
selection of TCRs with a selective advantage such as structural
features that are optimal for pMHC recognition.39
In SIV-infected rhesus macaques, the emergence of public
Gag-specific clonotypes correlates with protection and the
absolute number of shared clonotypes inversely correlates with
viral load.40 Similarly in humans, control of HIV-1 replication
in the absence of antiretroviral therapy is mediated by a few
TCR clonotypes which are selected in the context of the so-
called ‘protective MHC alleles’ HLA-B*57, HLA-B*27 and
HLA-B*58.41 These findings imply that certain clonotypes
shared across several distinct individuals can be reliably asso-
ciated with protective, beneficial immune responses and may
act as surrogate predictors of disease outcome.
TCR repertoire size
TCR repertoire composition
Antigen-experienced
Naive
Pre-selection
Antigen-experiencedNaivePre-selection
Thymic
selection
Clonal
selection
Figure 3 Size and composition of the pre-selection, naive and antigen-
experienced repertoires. TCR diversity is greatest in the pre-selection
repertoire (gray). Positive and negative selection in the thymus purges
the pre-selection repertoire of most specificities, creating a peripheral
naive repertoire that is substantially less diverse (green). In the peri-
phery, antigen exposure further narrows the repertoire over time leading
to clonal expansion of antigen-specific populations (blue). TCR diversity
is largely preserved throughout the human lifespan, except in infancy
and old age, but the net distribution of TCR clonotypes is altered. TCR,
T cell receptor.
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Many T cell malignancies are characterized by extreme clonal
skewing, with oligoclonal or even monoclonal T cell expansions.
Recently, Clemente et al.42 showed that in HLA-A21 patients
with T-large granular lymphocyte leukaemia, Vb17-expressing T
cells share a unique CDR3 sequence. Importantly, sequencing
depth in this study was sufficient to establish that this canonical
TCR-b sequence associated with T-large granular lymphocyte
leukaemia was largely undetectable in healthy individuals.
Similarly, another study following the outcome of autologous
stem cell transplantation for the treatment of juvenile idiopathic
arthritis suggested that TCR-b oligoclonality was linked to clini-
cal relapse.43 Two patients in complete remission displayed
diverse TCR-b CDR3 immediately following transplant and at
later follow-up time points, whereas the third patient presented
with oligoclonal CD81 T cell skewing in most Vb families and
relapsed within a month. Moreover, in the latter case, the domi-
nant clones were shown to have emerged both from the pre-
transplant pool and from de novo TCR rearrangement. Thus,
because TCR skewing arises in a predictable fashion following an
antigen-specific response, monitoring TCR oligoclonality and
tracking specific TCR clonotypes linked to malignancy, or other
immunological disorders, may prove beneficial in the clinical
setting.
TCR DIVERSITY IN HEALTH AND DISEASE
Inbred mice represent a powerful tool for the analysis of pre-
selection, immunologically naive and antigen-specific reper-
toires. Murine models first suggested that in a normal setting,
the formation of the TCR repertoire was H-2-dependent44 and
that TCR usage was altered in the context of autoimmune
disease.45,46 For instance, the non-obese diabetic mouse regu-
latory T cell (Treg) repertoire is significantly restricted com-
pared to conventional T cells and to Treg from wild-type
mice. Strikingly, this defect in generation of diversity is appar-
ent in rag2/2 B6 mice reconstituted with non-obese diabetic
bone marrow indicating a cell-intrinsic origin, i.e., indepen-
dent of the nature of the selecting thymic stroma. Furthermore,
using different congenic non-obese diabetic strains, it was
shown that Treg diversity was in fact regulated by a yet-uniden-
tified gene on chromosome 4.47 This suggests that unknown
genetic mechanisms may be at work to modulate diversity in
the Treg lineage, which in turn is critical to the establishment of
tolerance. Similarly in humans, TCR diversity is known to be
critical for homeostasis of Treg cells and suppressor function.
48
Therefore, understanding the mechanisms underlying the
formation of the Treg repertoire will further our understanding
of autoimmune disease and provide insight into how selection
of a dysfunctional repertoire leads to disease.
In humans, twin studies are invaluable tools for dissecting
the genetic factors underlying the shaping of the peripheral
repertoire. Examples of repertoire analysis in twins, particu-
larly hyperanalytical methods such as high-throughput sequen-
cing, are still scarce in the literature. Nonetheless, a few select
reports are already providing key information. The earliest
study of TCR-b usage by Gulwani-Akolkar et al.49 already
highlighted the influence of HLA alleles. HLA-identical siblings
were found to have the highest degree of similarity in the TCR-
b repertoire, whereas HLA-haploidentical or HLA-mismatched
siblings were dissimilar. Later, Davey et al.50 re-examined this
finding in seven pairs of monozygotic twins. The highest
degree of similarity was found in the youngest pair (aged 2)
and all other twins (aged 5–44) had at least one difference in
Vb segment usage. Four pairs of twins in this study had a
history of disease affecting either one (discordant) or both
individuals (concordant). In discordant pairs, notable differ-
ences were seen in CD81 T cell Vb usage. For instance, one
individual suffering from asthma showed a significant increase
in Vb8 usage and loss of Vb12, compared to their healthy twin.
Differences in Vb expression patterns were also noted in two
other pairs of discordant twins affected by Hodgkin’s lym-
phoma and by polycythemia vera. Interestingly, Vb usage
was also found to diverge in twins concordant for systemic
lupus erythematosus. The authors therefore suggested that
both environmental factors and genetic factors contributed
substantially to shaping the TCR repertoire. Thus, at birth,
monozygotic twins have near identical repertoires with respect
to Vb usage, but changes associated with an individual’s
unique history of antigen exposure arise over time.
A longitudinal study following monozygotic twins simulta-
neously infected with the same HIV-1 strain by intravenous
drug abuse suggested random TCR recruitment in various epi-
tope-specific responses. Over the course of the disease and
virus evolution, several Pol and Nef epitopes were found to
be concordant (shared between the twins), whereas others were
unique to either individual. Remarkably, in these individuals,
the TCR-b chain repertoires raised against the shared epitopes
were exclusively private. Thus, the identical genetic back-
ground and the concordant pathways of viral escape did not
lead to TCR sharing in this instance and the authors concluded
that the recruitment of pathogen-specific TCRs was essentially
stochastic.51 This finding therefore suggested that an indivi-
dual’s natural history of antigen exposure may be at least as
important as their genetic background in determining the
composition of the antigen-specific repertoire and that the
forces shaping the repertoire aremore complex than previously
thought.
TCR CLONOTYPES AS MARKERS OF DISEASE
Tracking and detecting TCR ‘signatures’ associated with spe-
cific human infections may prove problematic considering the
complexity and diversity of human pathogens. Even in cases
where TCR expansions can be reliably and accurately linked to
infection, developing diagnostic tools based on TCR clonotyp-
ing may be highly unpractical due to rapid onset and progres-
sion of disease, particularly in the case of acute infections.
Nonetheless, this approach may become an option in the con-
text of autoimmune disease or cancer. Indeed, for such disor-
ders, pathogenesis is usually slow and, at least in the case of
autoimmunity, the onset of symptoms and formal diagnosis
can take place several years after autoantibodies are first detec-
table in serum. TCR-based diagnoses might offer several prac-
tical advantages, as technical resolution is rapidly increasing
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with the development of high-throughput ‘next generation’
sequencing methodologies.
As discussed above, a number of studies suggest that Vb
usage is fairly predictable, based on the influence of HLA
alleles. Nevertheless, understanding how the composition of
the TCR repertoire is altered in the disease setting remains a
challenging task due to technical limitations on the one hand,
but also to the complex functional and genetic nature of the T
cell pool on the other hand. Studies of monozygotic twins that
are discordant for autoimmune diseases have been particularly
enlightening.
Fozza et al.52 looked at the repertoires of monozygotic twins
discordant for type 1 diabetes at the time of the study. In this
study, any individual was found to share more TCR-b clono-
types with their twin thanwith unrelated individuals. However,
the extent to which TCR-b repertoires overlapped was
unlinked to disease status. This is to be expected because the
presence of a given TCR sequence does necessarily implicate a
particular T cell clone in disease pathogenesis. Indeed, using
CD81 T cell clones derived from a pair of multiple sclerosis
(MS)-discordant twins, Somma et al.53 identified a number of
TCR-b implicated in the pathogenesis of MS which could be
clonally expanded either from the healthy or the affected twin.
In contrast, Utz et al.54 showed that bulk T cell cultures
harvested from monozygotic twins concordant for MS mobi-
lized the same TCR-a chains following challenge with myelin
basic protein, whereas TCR-a chains from discordant twins
were dissimilar. Another study has recently demonstrated that
the cerebrospinal fluid of MS patients is enriched with public
EBV-cross-reactive TCR clonotypes which, again, could serve
as potential markers of disease.55 Thus, in these examples, sim-
ilarities in Va and Vb usage were largely linked to genetic
factors and not critically influenced by nominal antigen.
Differential TCR usage in discordant twins could mirror the
role of T cell-mediated responses as drivers of autoimmune
disease and mapping how the TCR repertoire is altered by
various disease settings will be key to the establishment of
TCR-based diagnosticmethods. The discrepancies in the afore-
mentioned studies highlight the need for more rigorous and
more powerful sequencing approaches coupled to the iden-
tification of antigen-experienced T cell subpools. Indeed,
developments in T cell phenotyping by flow cytometry are also
moving apace, making it possible to identify specific TCRs
within a given T cell subpopulation. Determining the fre-
quency and distribution of particular TCR sequences among
discrete T cell subcompartments might yet prove to be extre-
mely powerful.56
Using ‘next-generation’ sequencing, a more recent study in
three pairs of healthy, monozygotic twins suggested that the
composition of the TCR repertoire at the CDR3 level was also
largely determined by genetic factors.57 V segment usage in
out-of-frame sequences was found to be more similar in twins
than in non-twins, indicating a genetically determined bias
prior to selection, in line with had been previously reported
by Genolet et al.20 Remarkably, monozygotic twins did not
share more in-frame sequences with their twin than with an
unrelated individual, indicating that certain TCR clonotypes
can be enriched and shared across a wide population irrespect-
ive of HLA type, as previously suggested by Robins et al.38 This
is in accordance with previous studies highlighting convergent
recombination as a major route for the generation of public
TCRs. Some of the sequences shared by multiple, unrelated
individuals may be enriched with clonotypes derived from
invariant populations such as invariant natural killer T cells,
mucosa-associated invariant T cells and germline-encoded,
mycoyl-reactive T cells.58 Such semi-invariant TCRs are likely
raised against common antigens and shared across the popu-
lation. Thus, if linked to certain infections, such TCRs could
become invaluable tools for the diagnosis of human disease
(Figure 4).
Some diseases are associated with the emergence of aberrant
clonotypes. All tr loci normally rearrange in cis, or in other
words, strictly within locus. In pathologies linked to chromo-
somal instability including variousmalignancies, trans rearran-
gements arise in the periphery at high frequency. Inversions on
chromosome 7 can give rise to Vc to DbJb recombination.
Such rearrangements represent less than 1 in 100 000 peri-
pheral blood lymphocytes in healthy individuals. However, in
patients with ataxia telangiectasia, the abundance of such clo-
notypes is increased 50- to 100-fold. Similarly, patients with
childhood acute lymphoid leukaemia of B-cell lineage present
with high frequency of IGHV/Ja hybrids.59 In various lym-
phomapatients, the V (D) J recombinationmachinery has been
implicated in abnormal interchromosomal joining. Thus, trans
rearrangements are abundant in such patients but either largely
absent or extremely rare in healthy individuals and may
become important diagnostic markers for several disorders
and malignancies (Figure 4).
CONCLUSIONS
T cells orchestrate a variety of immune responses against self-
and foreign antigen and the genetic basis of these responses is
encrypted in the TCR repertoire. Over the last two decades,
numerous studies have accumulated in the literature to suggest
that the composition of the TCR repertoire is a tightly regulated
quantity. The formation of the pre-selection and the naive
repertoires is largely determined by genetic factors, including
HLA type and genes encoding the components of the V (D) J
recombination and antigen processing machineries. Thus,
against a given haplotype, the TCR repertoire is a structured
immunological system. However, the statistical distribution of
TCR clonotypes incurs large changes over time according to the
personal history of antigen encounter. In some cases, even
HLA-identical monozygotic twins can raise different TCR
pools against the same antigen. Consequently, the TCR rep-
ertoire, albeit regulated, and governed by genetic forces, is none-
theless a large and complex system. How the repertoire differs
between distinct individuals, whether genetically identical or gen-
etically disparate, is poorly understood and dissecting the com-
position of the human repertoire in the antigen-experienced
compartment has long remained a challenge due to technical
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limitations. The methodology and the tools required for com-
prehensive genetic analysis of antigen receptors have only
recently begun to unravel the complexity of the T cell compart-
ment. Notably, numerous studies have described how the rep-
ertoire might be altered in the context of certain infections,
malignancies or immunological disorders. One trending theme
is that some pathologies provoke the emergence of specific TCR
clonotypes, which may prove to be invaluable immunological
‘signatures’ in the clinical setting. Such signatures include pub-
lic TCR chains raised against common pathogens, extreme
oligoclonality and TCR skewing as seen in many lymphoid
malignancies, unique clonotypes associated with autoimmune
disease or even aberrant TCR hybrid chains that are linked to
numerous immunological disorders. These may represent only
a few examples of the information encoded in the TCR
repertoire and our understanding of the forces governing the
complexity of the T cell compartment in health and disease may
be key to future diagnostic and therapeutic interventions.
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